WO1999016385A1 - Medical devices of shape memory alloys - Google Patents

Medical devices of shape memory alloys Download PDF

Info

Publication number
WO1999016385A1
WO1999016385A1 PCT/IL1998/000467 IL9800467W WO9916385A1 WO 1999016385 A1 WO1999016385 A1 WO 1999016385A1 IL 9800467 W IL9800467 W IL 9800467W WO 9916385 A1 WO9916385 A1 WO 9916385A1
Authority
WO
WIPO (PCT)
Prior art keywords
sma
configuration
austenitic
transformation
deformation
Prior art date
Application number
PCT/IL1998/000467
Other languages
French (fr)
Inventor
Josef Flomenblit
Nathaly Budigina
Jacob Richter
Original Assignee
Litana Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Litana Ltd. filed Critical Litana Ltd.
Priority to AU93650/98A priority Critical patent/AU9365098A/en
Publication of WO1999016385A1 publication Critical patent/WO1999016385A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22FCHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
    • C22F1/00Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
    • C22F1/006Resulting in heat recoverable alloys with a memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B2017/0649Coils or spirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30092Properties of materials and coating materials using shape memory or superelastic materials, e.g. nitinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0019Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0023Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply

Definitions

  • the invention relates to implantable medical devices, and more particularly, to implantable medical devices made of or have at least a portion made of a shape memory alloy (SMA), which are positioned in the body while being in an initial configuration, another deformed to a second, operational configuration (the configuration assumed by the device once deployed in the body).
  • SMA shape memory alloy
  • Implantable medical devices such as stents, heart valves, bone plates, staples, intrauterine contraceptive devices and the like must meet many requirements to be useful and safe for their intended purpose. For example, they must be chemically and biologically inert to living tissue and to be able to stay in position over extended periods of time. Furthermore, devices of the kind mentioned above must have the ability to expand from a contracted state, which facilitates insertion into body conduits or cavity, to a useful expanded diameter. This expansion is either accomplished by a forced expansion, such as in the case of certain kinds of stent by the action of a balloon-ended catheter, or by self-expansion such as by shape-memory effects.
  • SMAs shape memory alloys
  • Nitinol nickel-titanium alloy
  • SMAs shape memory effect results from metallurgical phase transformations.
  • Certain SMAs are characterized by a transition temperature or transition temperature range, above which the predominant metallurgical phase is termed “austenite” and below which the predominant metallurgical phase is termed “martensite”.
  • austenite or austenitic state
  • martensite or martensitic state
  • the transformations in fact occur over a range of temperatures and are commonly discussed with reference to M s and M f , the start and finish temperatures of the martensitic transformation, respectively, and A j and A f , the start and finish temperatures of the austenitic transformation, respectively. Transformation between these two phases is reversible such that the alloys may be treated to assume different shapes or configurations in the two phases and can reversibly switch between one shape to another when transformed from one phase to the other.
  • SMAs display an intermediate phase, between the austentic and martensitic states, known as the "R phase ". Transformation from austenite to the R phase can also be temperature induced, occur at a temperature referred to as "T R ".
  • the R phase alone does not impart a significant SME (its recoverable strain does not exceed 1%), in contrast to the austenite and martensite states, but rather is a phase strongly affecting the mechanical properties of the alloy and the SME.
  • Implantable medical devices made of SMA have been known in the art. See for example U.S. Patent Nos. 3,786,806, 4,485,816 and 5,037,427.
  • U.S. Patent 5,242,451 discloses a stent employing a unidirectional SME to conform into an operational shape, from an original basic shape of a smaller diameter.
  • U.S. Patent 5,562,641 a two-way SME is employed such that the austenitic transformation temperature is above body temperature and the martensitic transformation temperature is below body temperature, whereby the device retains its last conditioned state (e.g. austenite or martensite) at body temperature.
  • Patent 5,545,210 discloses a stent which is mechanically deformable while in a martensitic state into an operational configuration assumed by it when it is deployed in a tubular organ.
  • the stent of U.S. Patent 5,545,210 exhibits, in its operational configuration, a strain which is on the horizontal plateau of the stress-strain curve of the SMA.
  • U.S. Patent 5,624,508 disclosed a method for the manufacture of shape memory alloy (SMA) device with defined transformation temperature.
  • SMA shape memory alloy
  • stress-induced martensite principle rather than temperature-induced martensite, has likewise been employed in SMA-based medical devices, e.g. in U.S. Patent No. 4,665,906.
  • austenitic nitinol is deformed to form stress-induced martensite and held in its deformed configuration and martensitic state by a restraining member.
  • the device is introduced into the body in the deformed configuration, where it is released from the restraining member to return to its austenitic state and configuration without any temperature change.
  • the present invention relates to implantable medical devices such as stents, heart valves, bone plates, surgical clips or staples, tooth implants, bone fracture healing device, catheters, interuterine contraceptive devices, and the like.
  • shape memory device will be used to denote a device which is made entirely or having at least a functional portion made of a shape memory alloy (SMA).
  • functional portion means to denote a portion of the medical device which can change its configuration to perform a certain function within the body (e.g. anchoring, applying force on surrounding tissue, etc.).
  • the shape memory device of the invention utilizes some of the shape memory properties of the SMA for its function.
  • configuration should be understood as meaning either one or more of the shape, diameter, elasticity, mechanical properties, or any other mechanical and geometrical property of the SMA. The configuration is in fact a combination of all such properties.
  • the medical device of the invention has at least a functional portion comprising an SMA of the two-way shape memory type; namely, an SMA having two different "memorized" configurations, including one assumed by it in its austenitic state (to be referred to herein at times as the "austenitic configuration ”) and the other assumed by it in its martensitic state (to be referred to herein at times as the "martensitic configuration ").
  • Each of these different configurations is also typically characterized by a different geometrical shape, which will be referred to herein at times respectively as the "austenitic shape " and the "martensitic shape ".
  • the invention employs a mechanical deformation in martensite, having some properties resembling those of a plastic deformation, for deployment of the device within the body and to assume an operational shape, with a deformation strain which is less than the maximal recoverable strain (the term "recoverable strain " is to denote that by an increase of temperature above the austenitic temperature, the strain is released and the SMA conforms to its austenitic configuration).
  • the maximal recoverable strain can be improved and the fatigue resistance can be increased by having an intermediate R phase.
  • the device of the invention in accordance with some embodi- ments has an austenitic configuration such that the process of deformation from the martensitic state to the austenitic state is in a direction opposite to that of the process of mechanical deformation from the initial configuration to the operational configuration of the SMA.
  • the deformation of the austenitic transformation is in the same direction of the mechanical deformation.
  • MIMT strain-induced martensitic transformation -
  • MIMS mechanically-inducedmartensitic state
  • this property combined with the general mechanical properties of the SMA, further combined with the mechanical properties of a plastic element associated with the SMA, is used to advantage of preparing a composite element, having on the one hand, "simulated" plastic deformation properties (the are “simulated” because there results from the combined properties of two different materials which together in a certain range of their properties, and which plays a role in the mechanical deformation display together with plastic deformation properties) with however very strong mechanical strength in an operational state, without practically any recoil.
  • the present invention provides, a medical device for deployment in a body of an individual, comprising a shape memory alloy (SMA) portion having an austenitic and a martensitic state, with different memorized configurations in each of these states, and being transformable between the martensitic state to the austenitic state by an austenitic transformation occurring at an austenitic transformation temperature, and from the austenitic state to the martensitic state by a martensitic transformation occurring at a martensitic transformation temperature, the SMA being initially in a martensitic state and having an initial configuration which is either a memorized martensitic configuration of the SMA or a configuration assumed by the SMA portion by a mechanical deformation; the SMA portion being mechanically deformable from the initial configuration into an operational configuration to be assumed by it when deployed within the body; the SMA portion in the operational configuration is either in a martensitic state and having a memorized austenitic configuration to which it transforms when heated
  • the medical device is positioned into its intended place within the body when in its initial configuration and this converted to the operational configuration in which it remains deployed within the body.
  • the A f temperature (as well A s M s and M f ) can change as a result of a mechanical deformation.
  • a f which has changed as a result of a mechanical deformation will be identified by a " ' " indication, i.e. " A f ' ".
  • the SMA portion has in its operational configuration, an A f ' which is higher than physiological body temperature, T B , and an M s which is lower than T B ; the SMA portion being deformable, while retaining its martensitic state into said operational configuration; upon heating of the SMA portion to a temperature above A f ', it undergoes an austenitic transformation into the austenitic configuration, which is a different configuration than said operational configuration, with the SMA remaining in the austenitic configuration after the SMAs temperature returns back to T B .
  • the austenitic configuration may be such so that the transformation from the operational configuration to the austenitic configuration, when the device is heated to a temperature above A f , goes in a direction opposite to the forced deformation from the initial to the deployment configuration.
  • the transformation from the operational configuration to the austenitic configu- ration is in the same direction to that of said forced configuration.
  • the SMA has an undeformed martensitic configuration, namely a configuration assumed by it after undergoing a heat-induced martensitic transformation, which is about the same as the operational configuration.
  • internal stress sources will function to stabilize the SMA portion in the operational configuration.
  • the device has an intermediate state R, between the martensitic and the austenitic states, and having a transformation temperature from the austenitic state to the R state T R , which is higher than M s and being close to T B , such that at body temperature, the SMA portion is entirely or partially in the R state.
  • T R may be about 35°C and M s about 32°C.
  • the deformation of the SMA from the initial shape to the deployment shape is with a strain within a range of ⁇ ⁇ - ⁇ 2 , with ⁇ x being a strain level at an end of a horizontal plateau of a stress-strain curve of the SMA, and ⁇ 2 is an upper limit of deformation where recoverable by a shape memory effect (namely the upper limit of the deformation in which the device can still undergo an austenitic transformation into the austenitic configuration).
  • the SMA portion is made to assume its initial shape by an elastic deformation while in the martensitic state.
  • the forced deformation of the SMA portion causes an increase in the austenitic transformation temperature from initial start and finish transformation temperatures of the austenitic transformations, A s and A f , respectively, which are below T B , to austenitic start and finish transformations in the operational configuration, A,' and A f ', respectively, higher than T B .
  • the SMA portion in a device may be made to have an R phase with a T R close to T B , and may then be mechanically deformed such that at least one segment of the SMA portion remains in the R phase and at least one other segment is deformed with a strain at the range of ⁇
  • the SMA portion in its operational configuration, will have at least one segment (that which is in the R phase) which is relatively soft and flexible, and at least one segment (that deformed with a strain within the range of ⁇ ,- ⁇ 2 ) which has a high mechanical strength.
  • a medical device for deployment in a body of an individual comprising: a first component and a second component associated with one another, such that a deforming mechanical force cause both to deform together;
  • the first component comprising an SMA having an initial configuration in which the SMA is in a mechanically induced martensitic state (MIMS) resulting from a strain-induced or stress-induced martensitic transformation;
  • the second component having mechanical properties such that it resists deformation at a stress, ⁇ 2 , which is larger than stress generated by the SMA when released from said MIMS to the austenitic stress, ⁇ ,, thereby restraining said SMA in said initial state;
  • the SMA together with the second component are mechanically deformable from said initial configuration to an operational configuration, this deformation causing the SMA to transform from said MIMS to the austenitic state;
  • the plastic element yielding a reactive stress, ⁇ 2 , which is less than the resistive stress, ⁇ 3 of the deformation of the SMA
  • the second component in a device in accordance with the above embodiment may have plastic mechanical properties, i.e. a low recoil.
  • the SMA portion in such device provides resistance against the surrounding tissue, where the device has been deployed, which may be adjusted between 0 up to a level depending on the difference between ⁇ 4 (the stress during relaxation of the second component) and ⁇ 3 .
  • the second component may also be elastic, i.e.
  • the SMA portion having an R phase with a T R transformation temperature below T B , whereby cooling of the SMA to T R or below causing a very sharp drop of the SMAs elastic modulus giving rise to a decrease in the stiffness of the SMA portion, and the second component can then deform the SMA portion up to at least said initial configuration and maintain in this configuration, such that it can be removed or repositioned.
  • the second component may be made of a variety of materials including, for example, rubber, silicone, metal with different mechanical properties to the SMA, SMAs with different properties, polymeric plastic material, etc.
  • a device in accordance with the above embodiment combines the properties of the SMA and those of the second component so as to yield properties which during the mechanical deformation, simulate an essentially perfect plastic deformation; but if the SMA portion has an R phase and the SMA portion is transformed to said R phase by cooling temperature to T R , the device displays elastic properties. (Such combined properties, will be referred to herein as “simulated plastic deformation " or "simulated elastic deformation " properties, respectively).
  • Fig. 1 shows a stress-strain curve for three different shape memory alloys: a standard alloy displaying an austenitic to martensitic transformation (curve 1); an alloy displaying an austenitic to a martensitic transformation, with an intermediate R state, with M s being very much lower than T R (curve 2); and an alloy with an intermediate R state, but with M,. smaller than but very close to T R .
  • Fig. 2 shows the shift modulus as a function of the temperature, of an alloy of the kind of curve 3 in Fig. 1.
  • Fig. 3 shows a stress-strain curve for an SMA super-elastic (SE) component, and for a second component with different mechanical properties, which are combined together to yield a device displaying simulated plastic deformation properties.
  • SE super-elastic
  • Fig.4 illustrates an embodiment of a stent of the invention and its deployment in a tubular organ.
  • the stent has an austenitic configuration, such that the deformation from the martensitic to the austenitic state goes in a direction opposite to the mechanical deformation during deployment.
  • Fig. 5 shows a stent in accordance with another embodiment of the invention, and its deployment in a tubular organ.
  • the stent can undergo an austenitic transformation, which results in a configuration change which is in the same direction to that of the mechanical deformation during deployment.
  • Fig. 6 shows a stent in accordance with another embodiment, which is a composite element made of an SMA component, and another component having plastic or elastic deformation properties.
  • Fig. 7 shows a removable surgical staple, in accordance with an embodiment of the invention, where the austenitic transformation yields a deformation which is in a direction opposite to that of the mechanical deformation during deployment.
  • Fig.8 shows a surgical staple in accordance with another embodiment of the invention, where the austenitic transformation yields a deformation which goes in the same direction as the mechanical deformation during deployment.
  • Fig. 9 shows a bone fracture healing device, in accordance with the invention and its deployment to fix a bone fracture.
  • Fig. 10 shows a bone anchor device, where the SMA portion can undergo an austenitic transformation to increase the anchoring force.
  • Fig. 11 shows a bone anchoring device, comprising a second component.
  • the invention relates to a medical device having an SMA portion which is mechanically deformed from an initial configuration in which it is inserted into the body, to an operational configuration, which it assumes when deployed in the body.
  • the deformation is not elastic, since after the external deforming force is unloaded, the SMA portion remains in the deformed state.
  • the deformation is also not plastic, since, depending on the type of embodiment, the device can recover its austenitic configuration by austenitic transformation when heated to a temperature above A f , or alternatively, the SMA portion after the forced deformation is in the austenitic state (in the last embodiment described above).
  • the medical device of the invention may be any one of those mentioned above.
  • a medical device of the invention being a stent is a preferred embodiment of the invention, although the invention should definitely not be considered as being limited to this embodiment only.
  • Nitinol which is an alloy comprising primarily nickel and titanium, may also, at times, comprise other metals, typically in trace amounts, including copper (Cu), iron (Fe), chromium (Cr), vanadium (V).
  • the alloy comprises about 50 atomic % of both nickel (Ni) and titanium (Ti) with occasionally some of the nickel or the titanium being replaced by one of the abovementioned other metals, e.g. in a concentration range of 0.3-2 atomic %.
  • the medical device is inserted into the body in an initial configuration, adapted for such insertion, and then is deformed by a mechanical deformation into the operational configuration, in which it remains deployed within the body.
  • the initial configuration may be a configuration wherein the stent is coiled around the end of a balloon catheter; the balloon catheter is then used to mechanically deform and expand the stent into its operational configuration, where it has a wider diameter supporting the wall of a tubular organ.
  • the device of the invention may be made entirely of SMA, in which case said SMA portion will in fact constitute the entire device.
  • the medical device of the invention may have only a portion, a large or a small portion, which is made of an SMA possessing the two- way SME properties.
  • a medical device which is mechanically deformable from an initial state into an operational state, should ideally possess the following characteristics:
  • the device should be resistant to fatigue, particularly in the case of a varying reactive force, e.g. those applied on a stent by the walls of an artery. Fatigue resistance means in essence resistance against breaks;
  • SMA portion can undergo deformation with a considerable strain, e.g. about 10%, with strain recovery after heating (SME realization).
  • the device should have a minimal spring back (recoil).
  • the recoil is in fact an instantaneous, elastic deformation in a direction opposite to the forced deformation, which occurs immediately after force unloading (i.e. after stopping the application of force). Such recoil may cause disengagement between the SMA portion and the surrounding tissue, e.g. between a stent and the surrounding walls of an artery, and or as a result impairment in function and unwanted dislocation.
  • the present invention achieves the above objectives by employing an SMA of the two-way shape memory type, and particularly by making a novel use of the SMAs, state-dependent mechanical properties.
  • the letters A, M and R will be used to denote the austenitic state, the martensitic state and the R phase, respectively.
  • the conversion from one state to another will be used by indicating the letter of the starting phase or state connected by a hyphen to the letter pertaining to the resulting state or phase (for example, A-M denotes transformation from austenite to martensite).
  • Fig. 1 showing the strain-stress relationships of three different SMA alloys, represented by curves 1, 2 and 3. It should be noted that the point of intercept of each of these curves with the horizontal axis is arbitrary and the different curves are shifted along this axis for the sake of clear presentation.
  • Curve 1 shows the stress-strain relationships of an SMA which undergoes a deformation- induced A-M transformation.
  • the SMA is A until the bend 22 when the SMA enters into the horizontal plateau of strain-stress curve in which it converts from A to M.
  • the horizontal plateau 24 the SMA is relatively soft, and thus a small stress yields a relatively large deformation.
  • U.S. Patent 5,545,210 Hess et al.
  • the present invention is based on the realization that the transformation should preferably be to a strain within region 26 of the curve, mainly between ⁇ 1 and ⁇ .
  • ⁇ 2 is the maximal recoverable strain, namely where the SMA still retains its memory properties.
  • the SMA loses its shape memory properties and cannot recover all strain during M - A transformation.
  • the austenitic transformation temperature is also dependent on the degree of deformation, i.e. increases with increase in deformation).
  • the SMA as any alloy, has a maximal deformation which causes it to break, ⁇ B .
  • the extent of strain difference between a certain deformed configuration and the maximal strain ⁇ B is a measure of the fatigue resistance of the SMA: a large difference meaning a large fatigue resistance, and vice versa.
  • Segment 26 of the curve has in fact two portions, a lower portion 28, where the SMA has some elasticity, and an upper portion where the SMA is "plastic" (the SMA in this portion is not actually plastic and the deformation, even of this portion is not a real plastic deformation, since the martensite has a "memorized” austenitic configuration which is recoverable by a heat-induced transformation). It is preferred in accordance with the invention that the deformation will be to a strain where the SMA displays plastic-like properties (segment 30) on the one hand and large mechanical strength on the other hand.
  • ⁇ 2 in an SMA portion in a device of the invention is typically 8-12% (measured from the point of intersection of the curve with the horizontal axis).
  • A-R A to R
  • R-M R to M
  • the A-R transformation can also be temperature induced, at a transformation temperature T R .
  • T R is made to be larger than M S ⁇ and in the specific case of the SMA of curve 2, is considerably larger.
  • the M s is only slightly below, e.g. 1°C- 10°C below, T R .
  • One of the characteristics of the R phase is a low shift module at a temperature T R , as represented in Fig. 2.
  • T R is made to be about the same as the body temperature, i.e. about 37° C, which is the temperature in which the mechanical deformation is being carried out.
  • T R of the alloy is larger than M s , as aforesaid, but should be smaller than A s , which is above body temperature. This means that under mechanical deformation stresses, the SMA portion of the device transforms from A to R and then from R to martensite.
  • This A-R-M transformation has more stages than the previous case of the A-M transformation, including a first stage 40, where the SMA is A, a horizontal stage 42 where the A-R transformation occurs, a stage 44 where the SMA portion is the R, a horizontal stage 46 where the R-M transformation occurs and then the stage of reversible martensitic transformation (interaction of different martensitic variants) 48 which extends between strain rates ⁇ , and ⁇ 2 ( ⁇ , and ⁇ 2 in curve 2 may have different values than ⁇ 2 and ⁇ 2 in curve 1). The same applies for the values ⁇ 2 and ⁇ 2 of curve 3).
  • This multi-phase deformation curve allows an increase in total recoverable strain as compared to a one phase transformation.
  • an R phase decreases the elastic spring back (recoil) of the SMA.
  • the existence of an R phase provides a recoil of 12% and a recoverable strain of 11%; direct A-M deformation yields recoil of about 25%-28% and about 7.5% recoverable strain.
  • the SMA can be designed to have an initial austenitic transformation temperature (A s and A f ) which is lower than body temperature (T B ), with this transformation temperature increasing after the mechanical deformation to a temperature A.. ' and A f ' , which is above T B .
  • the austenitic transformation namely the temperature induced change in configuration between M to A, can be in the same or in the opposite direction of the mechanical deformation.
  • the device may be inserted into the body in the austenitic state and then mechanically deformed to a strain between ⁇ j - ⁇ 2 to give rise to a martensite with large mechanical strength.
  • the increase in austenitic transformation temperature to above T B ensures no spontaneous temperature-induced configuration recovery.
  • the original configuration may be recovered, e.g. for the purpose of removal or repositioning, by heating the SMA portion, e.g. by means of warm saline, by passing electric current, by a focused ultrasound radiation, and generally by any physiologically compatible heating method.
  • the austenitic transformation may also be in a direction which is the same as that of the mechanical deformation. This feature may be used for reinforcement of the device after the mechanical isothermal deformation, for increasing the device's strength and fatigue resistance and for reducing recoil.
  • An embodiment of the invention makes use of the combined mechanical properties of an SMA and of another material having plastic or elastic mechanical properties. Their combination, in accordance with the invention, results in an element with simulated plastic deformation properties, when deformed from an initial to an operational configuration; and under certain conditions, this element can deform back towards the initial configuration in a simulated elastic deformation.
  • an SMA and a plastic or elastic component to form a composite element having such properties can be in a variety of ways.
  • the SMA may be coated by the plastic or elastic component.
  • plastic or elastic restraining members may be fitted to an SMA in a manner that they will undergo joint deformation.
  • a particular example is the case of a stent which is to be deployed by deformation from a contracted, initial state, to an expanded operational state.
  • Such a stent may be made with the SMA coated by a plastic layer or may be made as an SMA spiral combined with one or more restraining members, e.g. several plastic bands fitted over the stent, a plastic sleeve accommodating the stent within it, etc.
  • a curve 50 showing the stress- strain relationships of an SMA in its deformation from an austenitic state (lower left hand corner) to the martensitic state (upper right hand corner).
  • Curve 50 has a lower segment 51 which shows the strain-stress relationships in a deformation between martensite and austenite (M-A) and the upper segment 52 shows the strain-stress relationships in the deformation between austenite to martensite (A-M).
  • curve 60 displaying the mechanical properties of a second component, e.g. made of a plastic.
  • curve 60 has also two segments, consisting of a lower segment showing the strain-stress relationships during relaxation, and an upper curve 62 showing a strain-stress relationship during extension.
  • the SMA in the composite element is initially in a strain-or- stress-induced martensitic state with a total deformation up to ⁇ x .
  • the SMA is restrained by the second component since its deformation from martensite to austenite exerts a stress ⁇ , while the resistance towards extension of the plastic element is ⁇ 2 .
  • deformation is forced, e.g. in the case of a stent from a contracted state to an extended state by the use of a balloon catheter, force which has to be applied has to be larger than the difference between ⁇ 2 and ⁇ ,.
  • the SMA portion displays a resistance to deformation in the opposite direction (namely from the operational state to the initial state), at a force ⁇ 3 .
  • This will the be mechanical resistance force of the SMA against deformation in this opposite direction.
  • the mechanical deformation stress in this opposite direction is a combination of that applied by the second component ⁇ 4 and that provided by the surrounding tissue. ⁇ 3 is larger than these combined forces and accordingly the SMA portion will resist this opposite deformation.
  • the composite element will display almost ideal plastic properties in its deformation from the initial to the operational configuration, with practically no recoil once reaching the operational configuration. Furthermore, it is clear that this element has a high mechanical strength against reactive forces which may be exerted by the surrounding tissue organ, namely its collapse. It is possible to construct the SMA portion such that it will also have an R phase, with a T R temperature below body temperature. In accordance with this embodiment, the SMA device may be cooled to T R whereupon it transforms to the R phase. In this phase, it has very low shift modulus and accordingly its resistance to transformation in the opposite direction becomes very low (below ⁇ 4) , and thus the force which will be applied by the second component will cause its deformation from the operational configuration to the initial configuration.
  • the former component is a plastic component with a very low recoil, and the latter is an elastic component with very high recoil.
  • the composite element provides a wide spectrum of adjustable pressure on the surrounding tissue. Where the second component is elastic, as pointed out above, cooling the temperature below T R , will cause a mechanical deformation towards the initial configuration.
  • stent 20 held on an end of a balloon catheter 22.
  • first step (a) stent 20 is brought into the deployment position, within the tubular organ 24, e.g. an artery, while in an initial position with a relatively low diameter, in which it is held on catheter 22.
  • Step (b) stent 20 is expanded by a balloon 26 of catheter 22, whereby the diameter of stent 20 increases to its deployment configuration.
  • This mechanical deformation is performed in martensite, with a deformation strain not exceeding ⁇ 2 while having high mechanical strength and being fatigue resistant.
  • the stent 22 can then be removed (Step (c)), and the stent will thus become deployed supporting the walls of the tubular organ.
  • the stent of this embodiment is designed so that it can undergo an austenitic transformation with a deformation which is in a direction opposite to that of the mechanical deformation.
  • the heating of the stent to a temperature above A,,' (Step (d)), e.g. by means of a warm saline, will cause the stent to shrink to its austenitic configuration, in which it can be removed or redeployed.
  • Step (a) and (b) are essentially similar to steps (a) and (b) of Fig. 4.
  • the stent 20' has been made such that the austenitic transformation causes a change in the configuration which goes in the same direction as the mechanical deformation.
  • Step (c) the stent increases in diameter and thereby exerts a stronger force on the surrounding tissue, as a result of the super elastic properties in the austenitic state.
  • Fig. 6 shows a stent 30, in accordance with another embodiment, which as can be seen in the cross section of the view on the left, is a composite material comprising an SMA 32, coated by another component 34, which may be a substance with plastic (low recoil ) properties, elastic (high recoil) properties, or intermediate properties between the two.
  • another component 34 which may be a substance with plastic (low recoil ) properties, elastic (high recoil) properties, or intermediate properties between the two.
  • association of the second component to the SMA may be by a variety of other means, e.g. containing an SMA stent within a sleeve made of a plastic substance, by adding one or more restraining members, etc.
  • the substance from which the second component is made may typically be a plastic polymeric material, e.g. cardiological polyurethane. However it may also be made from other substances, e.g. metal, rubber, etc.
  • the stent in the embodiment shown in Figs. 4-6 may have, for example, an initial diameter of 1.5-2.5 mm., and then may be expanded mechanically to a diameter of about 3.5-4.5 mm.
  • the deformation between a diameter of 2 mm. to a diameter of 3.5 mm. induces a strain of about 2%.
  • the deformation from 1.5 mm. to 4 mm. induces a strain of about 8%.
  • Fig. 7 shows a surgical staple 40, which has an initial straight shaped configuration 42 (a), and is then deformed mechanically in martensite, into a deployment configuration 44 (b).
  • the staple which is made of an SMA, has an austenitic configuration such that the austenitic transformation yields a deformation which goes in the direction opposite to the mechanical deformation.
  • the staple opens to its initial configuration, and can then be removed (c).
  • a similar surgical staple is shown, and accordingly like elements have been given like numbers with a prime indication.
  • the austentic transformation induces a deformation which goes in the same direction to that of the mechanical deformation, and accordingly, by heating a surgical staple with a higher strain deformation 46, is obtained (c). This serves to further strengthen the tissue binding properties of the staple.
  • Fig. 9 shows a bone fixation device (50), which comprises two members 52 and 54, which are screw fitted with one another, with member 54 having an external screw thread at its end 56, for a tight screw engagement with the surrounding bone tissue 58.
  • the device further comprises a tensioning cable 60, made of SMA.
  • a bore 64 is drilled in the bone, and the device is inserted until the end 56 is tightly screwed into the bone tissue at the end of the bore, and the head 66 of member 52, rests on the bone's exterior surface.
  • tensioning cable 60 becomes tensioned from its initial loose state (a) to a tensioned state (b).
  • the austenitic transformation gives rise to a deformation which is in the opposite direction to the mechanical deformation, and consequently, upon heating a temperature above A..' (c), cable 60 transforms to austenite and thus forces the two members 52 and 54 together _ o __
  • Fig. 10 shows a bone anchoring device.
  • the device generally designated 80, has a crown 82, and anchoring legs 84, made of an SMA.
  • the device further has a tensioning arrangement comprising a sphere 86, which is at the end of a rod 88, which is externally screw-threaded at its end 90, and a bolt 92 screw-coupled to end 90.
  • a mechanical tensioning force can be applied by turning bolt 92, pulling sphere 86 from its initial position (a) to a deployed position (b), with this yielding expansion of legs 84.
  • the SMA has an austenitic configuration, such that that the deformation in the austentic transformation is in the same direction to that of the mechanical deformation; accordingly, after heating to a temperature above A., (c) legs 84, expand even further and provide, by virtue of their super- elasticity, a constant force on the surrounding bone tissue.
  • a bone anchoring device is shown in Fig. 11. Similar elements to those of Fig. 10 have been given the same reference numeral as in Fig. 10 within the prime indication. In this case, anchoring legs 94 are in an MIMS, and are maintained in that state, by the restraining force of plastic band 96. By the application of mechanical force, legs 94. epand, transforming into austenite against the mechanical force of band 96; the overall effect is that of a simulated plastic deformation, ensuring that the mechanical deformation will be a simulated plastic deformation.

Abstract

A medical device such as a stent, surgical staple, bone anchoring device or bone fixation device, intended to be deployed within the body, composes a shape memory alloy (SMA) portion with an austenitic and unaustenitic state with different memorized configurations in each of these states. The SMA which is initially in an initial configuration in which it can be placed into position within the body, can be mechanically deformed into an operational configuration in which it remains deployed within the body.

Description

MEDICAL DEVICES OF SHAPE MEMORY ALLOYS
FIELD OF THE INTENTION
The invention relates to implantable medical devices, and more particularly, to implantable medical devices made of or have at least a portion made of a shape memory alloy (SMA), which are positioned in the body while being in an initial configuration, another deformed to a second, operational configuration (the configuration assumed by the device once deployed in the body).
BACKGROUND OF THE INVENTION AND PRIOR ART Implantable medical devices, such as stents, heart valves, bone plates, staples, intrauterine contraceptive devices and the like must meet many requirements to be useful and safe for their intended purpose. For example, they must be chemically and biologically inert to living tissue and to be able to stay in position over extended periods of time. Furthermore, devices of the kind mentioned above must have the ability to expand from a contracted state, which facilitates insertion into body conduits or cavity, to a useful expanded diameter. This expansion is either accomplished by a forced expansion, such as in the case of certain kinds of stent by the action of a balloon-ended catheter, or by self-expansion such as by shape-memory effects.
There are many alloys which display a shape memory effect (SME), known generically as shape memory alloys (SMAs). A widely used metal alloy, particularly for metal applications, is the nickel-titanium alloy, known as "nitinol". Under certain conditions, SMAs can be highly elastic such that they are able to undergo extensive deformation and yet return to their original shape. Furthermore, SMAs possess shape memory properties such that they can "remember" a specific shape imposed during a particular heat treatment and can return to that imposed shape under certain conditions. _ _
The shape memory effect of SMAs results from metallurgical phase transformations. Certain SMAs are characterized by a transition temperature or transition temperature range, above which the predominant metallurgical phase is termed "austenite" and below which the predominant metallurgical phase is termed "martensite". The transformation from austenite (or austenitic state) to martensite (or martensitic state) is termed "martensitic transformation "; the reverse transformation from austensite to martensite is termed as "austenitic transformation ". The transformations in fact occur over a range of temperatures and are commonly discussed with reference to Ms and Mf, the start and finish temperatures of the martensitic transformation, respectively, and Aj and Af, the start and finish temperatures of the austenitic transformation, respectively. Transformation between these two phases is reversible such that the alloys may be treated to assume different shapes or configurations in the two phases and can reversibly switch between one shape to another when transformed from one phase to the other. Occasionally, SMAs display an intermediate phase, between the austentic and martensitic states, known as the "R phase ". Transformation from austenite to the R phase can also be temperature induced, occur at a temperature referred to as "TR ". The R phase alone does not impart a significant SME (its recoverable strain does not exceed 1%), in contrast to the austenite and martensite states, but rather is a phase strongly affecting the mechanical properties of the alloy and the SME.
Implantable medical devices made of SMA have been known in the art. See for example U.S. Patent Nos. 3,786,806, 4,485,816 and 5,037,427. U.S. Patent 5,242,451 discloses a stent employing a unidirectional SME to conform into an operational shape, from an original basic shape of a smaller diameter. In U.S. Patent 5,562,641, a two-way SME is employed such that the austenitic transformation temperature is above body temperature and the martensitic transformation temperature is below body temperature, whereby the device retains its last conditioned state (e.g. austenite or martensite) at body temperature. U.S. Patent 5,545,210 discloses a stent which is mechanically deformable while in a martensitic state into an operational configuration assumed by it when it is deployed in a tubular organ. The stent of U.S. Patent 5,545,210 exhibits, in its operational configuration, a strain which is on the horizontal plateau of the stress-strain curve of the SMA. U.S. Patent 5,624,508 disclosed a method for the manufacture of shape memory alloy (SMA) device with defined transformation temperature.
The use of stress-induced martensite principle, rather than temperature-induced martensite, has likewise been employed in SMA-based medical devices, e.g. in U.S. Patent No. 4,665,906. In such devices, austenitic nitinol is deformed to form stress-induced martensite and held in its deformed configuration and martensitic state by a restraining member. The device is introduced into the body in the deformed configuration, where it is released from the restraining member to return to its austenitic state and configuration without any temperature change.
GENERAL DESCRIPTION OF THE INVENTION
The present invention relates to implantable medical devices such as stents, heart valves, bone plates, surgical clips or staples, tooth implants, bone fracture healing device, catheters, interuterine contraceptive devices, and the like.
In the following, the term "shape memory device " will be used to denote a device which is made entirely or having at least a functional portion made of a shape memory alloy (SMA). The term "functional portion " means to denote a portion of the medical device which can change its configuration to perform a certain function within the body (e.g. anchoring, applying force on surrounding tissue, etc.). The shape memory device of the invention utilizes some of the shape memory properties of the SMA for its function. The term "configuration " should be understood as meaning either one or more of the shape, diameter, elasticity, mechanical properties, or any other mechanical and geometrical property of the SMA. The configuration is in fact a combination of all such properties. The medical device of the invention has at least a functional portion comprising an SMA of the two-way shape memory type; namely, an SMA having two different "memorized" configurations, including one assumed by it in its austenitic state (to be referred to herein at times as the "austenitic configuration ") and the other assumed by it in its martensitic state (to be referred to herein at times as the "martensitic configuration "). Each of these different configurations is also typically characterized by a different geometrical shape, which will be referred to herein at times respectively as the "austenitic shape " and the "martensitic shape ". The invention, by some of its embodiments, employs a mechanical deformation in martensite, having some properties resembling those of a plastic deformation, for deployment of the device within the body and to assume an operational shape, with a deformation strain which is less than the maximal recoverable strain (the term "recoverable strain " is to denote that by an increase of temperature above the austenitic temperature, the strain is released and the SMA conforms to its austenitic configuration). By some embodiments, the maximal recoverable strain can be improved and the fatigue resistance can be increased by having an intermediate R phase.
The device of the invention in accordance with some embodi- ments has an austenitic configuration such that the process of deformation from the martensitic state to the austenitic state is in a direction opposite to that of the process of mechanical deformation from the initial configuration to the operational configuration of the SMA. In other embodiments, the deformation of the austenitic transformation is in the same direction of the mechanical deformation.
By another embodiment of the invention use is made of the SMAs ability to undergo a strain-induced or a stress-induced mechanical transformation ("mechanically -induced martensitic transformation - "MIMT"), to yield a mechanically-inducedmartensitic state ("MIMS"). Specifically, this property, combined with the general mechanical properties of the SMA, further combined with the mechanical properties of a plastic element associated with the SMA, is used to advantage of preparing a composite element, having on the one hand, "simulated" plastic deformation properties (the are "simulated" because there results from the combined properties of two different materials which together in a certain range of their properties, and which plays a role in the mechanical deformation display together with plastic deformation properties) with however very strong mechanical strength in an operational state, without practically any recoil.
The present invention provides, a medical device for deployment in a body of an individual, comprising a shape memory alloy (SMA) portion having an austenitic and a martensitic state, with different memorized configurations in each of these states, and being transformable between the martensitic state to the austenitic state by an austenitic transformation occurring at an austenitic transformation temperature, and from the austenitic state to the martensitic state by a martensitic transformation occurring at a martensitic transformation temperature, the SMA being initially in a martensitic state and having an initial configuration which is either a memorized martensitic configuration of the SMA or a configuration assumed by the SMA portion by a mechanical deformation; the SMA portion being mechanically deformable from the initial configuration into an operational configuration to be assumed by it when deployed within the body; the SMA portion in the operational configuration is either in a martensitic state and having a memorized austenitic configuration to which it transforms when heated to a temperature, equal or above the austenitic transformation temperature, which is above body temperature, or is in an austenitic state, to which it transformed during the mechanical deformation.
The medical device is positioned into its intended place within the body when in its initial configuration and this converted to the operational configuration in which it remains deployed within the body.
The Af temperature (as well As Ms and Mf) can change as a result of a mechanical deformation. Af which has changed as a result of a mechanical deformation will be identified by a " ' " indication, i.e. " Af' ". By one embodiment of the invention, the SMA portion has in its operational configuration, an Af ' which is higher than physiological body temperature, TB, and an Ms which is lower than TB; the SMA portion being deformable, while retaining its martensitic state into said operational configuration; upon heating of the SMA portion to a temperature above Af', it undergoes an austenitic transformation into the austenitic configuration, which is a different configuration than said operational configuration, with the SMA remaining in the austenitic configuration after the SMAs temperature returns back to TB. The austenitic configuration may be such so that the transformation from the operational configuration to the austenitic configuration, when the device is heated to a temperature above Af, goes in a direction opposite to the forced deformation from the initial to the deployment configuration. In accordance with another embodiment, the transformation from the operational configuration to the austenitic configu- ration is in the same direction to that of said forced configuration.
In accordance with one embodiment of the invention, the SMA has an undeformed martensitic configuration, namely a configuration assumed by it after undergoing a heat-induced martensitic transformation, which is about the same as the operational configuration. In such an SMA, internal stress sources will function to stabilize the SMA portion in the operational configuration.
According to another embodiment, the device has an intermediate state R, between the martensitic and the austenitic states, and having a transformation temperature from the austenitic state to the R state TR, which is higher than Ms and being close to TB, such that at body temperature, the SMA portion is entirely or partially in the R state. For example, TR may be about 35°C and Ms about 32°C.
In accordance with an embodiment of the invention the deformation of the SMA from the initial shape to the deployment shape is with a strain within a range of εα- ε2, with εx being a strain level at an end of a horizontal plateau of a stress-strain curve of the SMA, and ε2 is an upper limit of deformation where recoverable by a shape memory effect (namely the upper limit of the deformation in which the device can still undergo an austenitic transformation into the austenitic configuration). Typically, the SMA portion is made to assume its initial shape by an elastic deformation while in the martensitic state. In accordance with a further embodiment of the invention, the forced deformation of the SMA portion causes an increase in the austenitic transformation temperature from initial start and finish transformation temperatures of the austenitic transformations, As and Af, respectively, which are below TB, to austenitic start and finish transformations in the operational configuration, A,' and Af', respectively, higher than TB.
The SMA portion in a device according to the latter embodiment, may be made to have an R phase with a TR close to TB, and may then be mechanically deformed such that at least one segment of the SMA portion remains in the R phase and at least one other segment is deformed with a strain at the range of ε^ε^ Thus, in its operational configuration, the SMA portion will have at least one segment (that which is in the R phase) which is relatively soft and flexible, and at least one segment (that deformed with a strain within the range of ε ,-ε2) which has a high mechanical strength.
According to another embodiment of the invention there is provided a medical device for deployment in a body of an individual, comprising: a first component and a second component associated with one another, such that a deforming mechanical force cause both to deform together; the first component comprising an SMA having an initial configuration in which the SMA is in a mechanically induced martensitic state (MIMS) resulting from a strain-induced or stress-induced martensitic transformation; the second component having mechanical properties such that it resists deformation at a stress, σ2, which is larger than stress generated by the SMA when released from said MIMS to the austenitic stress, σ,, thereby restraining said SMA in said initial state; the SMA together with the second component are mechanically deformable from said initial configuration to an operational configuration, this deformation causing the SMA to transform from said MIMS to the austenitic state; the plastic element yielding a reactive stress, σ2, which is less than the resistive stress, σ3 of the deformation of the SMA from the operational configuration to said initial configuration, whereby the device is retained in said operational configuration. The second component in a device in accordance with the above embodiment, may have plastic mechanical properties, i.e. a low recoil. The SMA portion in such device provides resistance against the surrounding tissue, where the device has been deployed, which may be adjusted between 0 up to a level depending on the difference between σ4 (the stress during relaxation of the second component) and σ3. The second component may also be elastic, i.e. have a high recoil, up to about 100%, with the SMA portion having an R phase with a TR transformation temperature below TB, whereby cooling of the SMA to TR or below causing a very sharp drop of the SMAs elastic modulus giving rise to a decrease in the stiffness of the SMA portion, and the second component can then deform the SMA portion up to at least said initial configuration and maintain in this configuration, such that it can be removed or repositioned.
The second component may be made of a variety of materials including, for example, rubber, silicone, metal with different mechanical properties to the SMA, SMAs with different properties, polymeric plastic material, etc.
A device in accordance with the above embodiment, combines the properties of the SMA and those of the second component so as to yield properties which during the mechanical deformation, simulate an essentially perfect plastic deformation; but if the SMA portion has an R phase and the SMA portion is transformed to said R phase by cooling temperature to TR, the device displays elastic properties. (Such combined properties, will be referred to herein as "simulated plastic deformation " or "simulated elastic deformation " properties, respectively). The invention will now be further illustrated in the following non-limiting specific embodiment with occasional reference to the annexed drawings:
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 shows a stress-strain curve for three different shape memory alloys: a standard alloy displaying an austenitic to martensitic transformation (curve 1); an alloy displaying an austenitic to a martensitic transformation, with an intermediate R state, with Ms being very much lower than TR (curve 2); and an alloy with an intermediate R state, but with M,. smaller than but very close to TR.
Fig. 2 shows the shift modulus as a function of the temperature, of an alloy of the kind of curve 3 in Fig. 1.
Fig. 3 shows a stress-strain curve for an SMA super-elastic (SE) component, and for a second component with different mechanical properties, which are combined together to yield a device displaying simulated plastic deformation properties.
Fig.4 illustrates an embodiment of a stent of the invention and its deployment in a tubular organ. In this embodiment, the stent has an austenitic configuration, such that the deformation from the martensitic to the austenitic state goes in a direction opposite to the mechanical deformation during deployment.
Fig. 5 shows a stent in accordance with another embodiment of the invention, and its deployment in a tubular organ. In this case, the stent can undergo an austenitic transformation, which results in a configuration change which is in the same direction to that of the mechanical deformation during deployment.
Fig. 6 shows a stent in accordance with another embodiment, which is a composite element made of an SMA component, and another component having plastic or elastic deformation properties. Fig. 7 shows a removable surgical staple, in accordance with an embodiment of the invention, where the austenitic transformation yields a deformation which is in a direction opposite to that of the mechanical deformation during deployment. Fig.8 shows a surgical staple in accordance with another embodiment of the invention, where the austenitic transformation yields a deformation which goes in the same direction as the mechanical deformation during deployment.
Fig. 9 shows a bone fracture healing device, in accordance with the invention and its deployment to fix a bone fracture.
Fig. 10 shows a bone anchor device, where the SMA portion can undergo an austenitic transformation to increase the anchoring force.
Fig. 11 shows a bone anchoring device, comprising a second component.
DETAILED DESCRIPTION OF THE INVENTION
The invention relates to a medical device having an SMA portion which is mechanically deformed from an initial configuration in which it is inserted into the body, to an operational configuration, which it assumes when deployed in the body. The deformation is not elastic, since after the external deforming force is unloaded, the SMA portion remains in the deformed state. However, the deformation is also not plastic, since, depending on the type of embodiment, the device can recover its austenitic configuration by austenitic transformation when heated to a temperature above Af, or alternatively, the SMA portion after the forced deformation is in the austenitic state (in the last embodiment described above).
The medical device of the invention may be any one of those mentioned above. A medical device of the invention being a stent is a preferred embodiment of the invention, although the invention should definitely not be considered as being limited to this embodiment only. Occasionally, in the following text, reference will be made specifically to a medical device being a stent, this being meant for illustration purposes only.
The SMA used in accordance with the invention may be any of a variety of such alloys known in the art, nitinol being preferred. Nitinol, which is an alloy comprising primarily nickel and titanium, may also, at times, comprise other metals, typically in trace amounts, including copper (Cu), iron (Fe), chromium (Cr), vanadium (V). The alloy comprises about 50 atomic % of both nickel (Ni) and titanium (Ti) with occasionally some of the nickel or the titanium being replaced by one of the abovementioned other metals, e.g. in a concentration range of 0.3-2 atomic %.
The medical device is inserted into the body in an initial configuration, adapted for such insertion, and then is deformed by a mechanical deformation into the operational configuration, in which it remains deployed within the body. For example, in the case of a stent, the initial configuration may be a configuration wherein the stent is coiled around the end of a balloon catheter; the balloon catheter is then used to mechanically deform and expand the stent into its operational configuration, where it has a wider diameter supporting the wall of a tubular organ. The device of the invention may be made entirely of SMA, in which case said SMA portion will in fact constitute the entire device. Alternatively, in some cases the medical device of the invention may have only a portion, a large or a small portion, which is made of an SMA possessing the two- way SME properties. A medical device which is mechanically deformable from an initial state into an operational state, should ideally possess the following characteristics:
(a) after the forced mechanical deformation, it should have the mechanical strength so as to resist any reactive forces from the surrounding tissue, so that it will not collapse; (b) The device should be resistant to fatigue, particularly in the case of a varying reactive force, e.g. those applied on a stent by the walls of an artery. Fatigue resistance means in essence resistance against breaks;
(c) It should have a maximal recoverable strain to provide a wide spectrum of design of the SMA portion. This means in essence, that the
SMA portion can undergo deformation with a considerable strain, e.g. about 10%, with strain recovery after heating (SME realization).
(d) The device should have a minimal spring back (recoil). The recoil is in fact an instantaneous, elastic deformation in a direction opposite to the forced deformation, which occurs immediately after force unloading (i.e. after stopping the application of force). Such recoil may cause disengagement between the SMA portion and the surrounding tissue, e.g. between a stent and the surrounding walls of an artery, and or as a result impairment in function and unwanted dislocation. The present invention achieves the above objectives by employing an SMA of the two-way shape memory type, and particularly by making a novel use of the SMAs, state-dependent mechanical properties.
In the following, the letters A, M and R will be used to denote the austenitic state, the martensitic state and the R phase, respectively. The conversion from one state to another will be used by indicating the letter of the starting phase or state connected by a hyphen to the letter pertaining to the resulting state or phase (for example, A-M denotes transformation from austenite to martensite). Reference is made first to Fig. 1 showing the strain-stress relationships of three different SMA alloys, represented by curves 1, 2 and 3. It should be noted that the point of intercept of each of these curves with the horizontal axis is arbitrary and the different curves are shifted along this axis for the sake of clear presentation. Curve 1 shows the stress-strain relationships of an SMA which undergoes a deformation- induced A-M transformation. In the first vertical part of the curve 20 the SMA is A until the bend 22 when the SMA enters into the horizontal plateau of strain-stress curve in which it converts from A to M. In the horizontal plateau 24 the SMA is relatively soft, and thus a small stress yields a relatively large deformation. In U.S. Patent 5,545,210 (Hess et al.) it is proposed to use a stent which when permanently positioned in a tubular organ, exhibits a strain which is on the horizontal plateau 24, i.e. a strain below ε It may be appreciated that such a stent will exhibit a relatively small mechanical strength. The present invention is based on the realization that the transformation should preferably be to a strain within region 26 of the curve, mainly between ε1 and ε . ε2 is the maximal recoverable strain, namely where the SMA still retains its memory properties. At a strain above ε2 the SMA loses its shape memory properties and cannot recover all strain during M - A transformation. (In fact, it should be noted that the austenitic transformation temperature is also dependent on the degree of deformation, i.e. increases with increase in deformation).
It should be noted, that the SMA, as any alloy, has a maximal deformation which causes it to break, εB. The extent of strain difference between a certain deformed configuration and the maximal strain εB, is a measure of the fatigue resistance of the SMA: a large difference meaning a large fatigue resistance, and vice versa.
Segment 26 of the curve has in fact two portions, a lower portion 28, where the SMA has some elasticity, and an upper portion where the SMA is "plastic" (the SMA in this portion is not actually plastic and the deformation, even of this portion is not a real plastic deformation, since the martensite has a "memorized" austenitic configuration which is recoverable by a heat-induced transformation). It is preferred in accordance with the invention that the deformation will be to a strain where the SMA displays plastic-like properties (segment 30) on the one hand and large mechanical strength on the other hand. ε2 in an SMA portion in a device of the invention is typically 8-12% (measured from the point of intersection of the curve with the horizontal axis).
The deformation of the medical device to a strain within the range of ε12 where it displays much higher mechanical strength than conventional mechanically deformed medical devices, particularly stents. (Hitherto, mechanically deformable medical devices were deployed by deformation to a strain in the range of the horizontal plateau, as noted above). This increase strength allows the medical device of the invention to better resist reaction forces exerted on the device by surrounding tissues or organs. While not wishing to be bound by theory, it is believed that strengthening of the device by deforming it into the region α2 occurs by the interaction between dislocations and martensite plates of different variants. Curve 2 in Fig. 1, relates to an SMA having an intermediate R phase between A and M and thus undergoes a mechanically induced transformation first from A to R (A-R) and then from R to M (R-M). The A-R transformation can also be temperature induced, at a transformation temperature TR. TR, is made to be larger than M and in the specific case of the SMA of curve 2, is considerably larger. Against this, in curve 3 which relates to an alloy which also undergoes an A-R-M deformation induced transformation, the Ms is only slightly below, e.g. 1°C- 10°C below, TR. One of the characteristics of the R phase is a low shift module at a temperature TR, as represented in Fig. 2. In the case of the present invention TR is made to be about the same as the body temperature, i.e. about 37° C, which is the temperature in which the mechanical deformation is being carried out. TR of the alloy, is larger than Ms, as aforesaid, but should be smaller than As, which is above body temperature. This means that under mechanical deformation stresses, the SMA portion of the device transforms from A to R and then from R to martensite. This A-R-M transformation has more stages than the previous case of the A-M transformation, including a first stage 40, where the SMA is A, a horizontal stage 42 where the A-R transformation occurs, a stage 44 where the SMA portion is the R, a horizontal stage 46 where the R-M transformation occurs and then the stage of reversible martensitic transformation (interaction of different martensitic variants) 48 which extends between strain rates ε, and ε2 (ε, and ε2 in curve 2 may have different values than ε2 and ε2 in curve 1). The same applies for the values ε2 and ε2 of curve 3). This multi-phase deformation curve allows an increase in total recoverable strain as compared to a one phase transformation.
Small differences between TR and Ms gives rise to an R-M transformation under favorable conditions of decreased elastic modules (see again Fig. 2). An alloy where Ms and TR are very close to one another, is that which yields curve 3 in Fig. 1. The R and M in fact "blend" with one another to yield a relatively wide range of ε j-ε,, in which the "plastic" deformation occurs, yielding a strong, deformation resistance configuration in martensite.
In addition to the larger recoverable strain of an SMA with an R state, the decrease in the elastic shift modulus increases the strain where break may occur, ε3, thus yielding an increase in the fatigue resistance of the SMA. This is particularly apparent in the case of curve 3 where Ms is close to TR.
In addition, the existence of an R phase decreases the elastic spring back (recoil) of the SMA. For example, in the case of a wire intended to be used as a force element of a bone fracture healing device, the existence of an R phase provides a recoil of 12% and a recoverable strain of 11%; direct A-M deformation yields recoil of about 25%-28% and about 7.5% recoverable strain.
Another property which is utilized in accordance with the invention is the increase in the austenitic transformation temperatures, which was already pointed out above. The SMA can be designed to have an initial austenitic transformation temperature (As and Af) which is lower than body temperature (TB), with this transformation temperature increasing after the mechanical deformation to a temperature A..' and Af ', which is above TB. The austenitic transformation, namely the temperature induced change in configuration between M to A, can be in the same or in the opposite direction of the mechanical deformation. Where the austenitic transformation occurs in the opposite direction of the mechanical deformation, the device may be inserted into the body in the austenitic state and then mechanically deformed to a strain between εj2 to give rise to a martensite with large mechanical strength. The increase in austenitic transformation temperature to above TB ensures no spontaneous temperature-induced configuration recovery. The original configuration may be recovered, e.g. for the purpose of removal or repositioning, by heating the SMA portion, e.g. by means of warm saline, by passing electric current, by a focused ultrasound radiation, and generally by any physiologically compatible heating method. The austenitic transformation may also be in a direction which is the same as that of the mechanical deformation. This feature may be used for reinforcement of the device after the mechanical isothermal deformation, for increasing the device's strength and fatigue resistance and for reducing recoil.
An embodiment of the invention makes use of the combined mechanical properties of an SMA and of another material having plastic or elastic mechanical properties. Their combination, in accordance with the invention, results in an element with simulated plastic deformation properties, when deformed from an initial to an operational configuration; and under certain conditions, this element can deform back towards the initial configuration in a simulated elastic deformation.
The combination of an SMA and a plastic or elastic component to form a composite element having such properties can be in a variety of ways. For example, the SMA may be coated by the plastic or elastic component. Additionally, plastic or elastic restraining members may be fitted to an SMA in a manner that they will undergo joint deformation. A particular example is the case of a stent which is to be deployed by deformation from a contracted, initial state, to an expanded operational state. Such a stent may be made with the SMA coated by a plastic layer or may be made as an SMA spiral combined with one or more restraining members, e.g. several plastic bands fitted over the stent, a plastic sleeve accommodating the stent within it, etc.
The properties of such composite elements can best be understood with reference to Fig. 3. In Fig. 3, a curve 50, showing the stress- strain relationships of an SMA in its deformation from an austenitic state (lower left hand corner) to the martensitic state (upper right hand corner). Curve 50 has a lower segment 51 which shows the strain-stress relationships in a deformation between martensite and austenite (M-A) and the upper segment 52 shows the strain-stress relationships in the deformation between austenite to martensite (A-M).
Also seen in Fig. 3, is curve 60 displaying the mechanical properties of a second component, e.g. made of a plastic. Similarly as curve 50, curve 60 has also two segments, consisting of a lower segment showing the strain-stress relationships during relaxation, and an upper curve 62 showing a strain-stress relationship during extension.
The SMA in the composite element is initially in a strain-or- stress-induced martensitic state with a total deformation up to εx. In this state, the SMA is restrained by the second component since its deformation from martensite to austenite exerts a stress σ, while the resistance towards extension of the plastic element is σ2. When deformation is forced, e.g. in the case of a stent from a contracted state to an extended state by the use of a balloon catheter, force which has to be applied has to be larger than the difference between σ2 and σ,.
While the deformation from the initial state to the operational state, which is an M-A deformation, procedes along the lower curve 51, the opposite deformation, A-M deformation, procedes along the upper curve 52; thus the SMA portion displays a resistance to deformation in the opposite direction (namely from the operational state to the initial state), at a force σ3. This will the be mechanical resistance force of the SMA against deformation in this opposite direction. The mechanical deformation stress in this opposite direction is a combination of that applied by the second component σ4 and that provided by the surrounding tissue. σ3 is larger than these combined forces and accordingly the SMA portion will resist this opposite deformation.
Given all the above, it is clear that the composite element will display almost ideal plastic properties in its deformation from the initial to the operational configuration, with practically no recoil once reaching the operational configuration. Furthermore, it is clear that this element has a high mechanical strength against reactive forces which may be exerted by the surrounding tissue organ, namely its collapse. It is possible to construct the SMA portion such that it will also have an R phase, with a TR temperature below body temperature. In accordance with this embodiment, the SMA device may be cooled to TR whereupon it transforms to the R phase. In this phase, it has very low shift modulus and accordingly its resistance to transformation in the opposite direction becomes very low (below σ4), and thus the force which will be applied by the second component will cause its deformation from the operational configuration to the initial configuration.
The second component, whose stress-strain relationship is shown in fig. 3, has some elasticity and some recoil, seeing that σ4 is different than the zero. It is obviously also possible to have this component entirely plastic (σ4 = 0 ) ; or alternatively, it is possible that this component be elastic, (σ4 will be about the same as σ2) whereby extension and relaxation will proceed long the same curve. The former component is a plastic component with a very low recoil, and the latter is an elastic component with very high recoil. In the case of the second component being plastic (σ4 = about 0), the composite element provides a wide spectrum of adjustable pressure on the surrounding tissue. Where the second component is elastic, as pointed out above, cooling the temperature below TR, will cause a mechanical deformation towards the initial configuration.
It is possible also to use a plastic element which changes its mechanical properties after loading:σ2 after one loading will be less than before loading. Such a composite element will have similar properties to those discussed with reference to Fig. 3. Some examples of medical devices in accordance with the invention will now be described.
Reference is first being made to Fig. 4, showing a stent 20 held on an end of a balloon catheter 22. In the first step (a), stent 20 is brought into the deployment position, within the tubular organ 24, e.g. an artery, while in an initial position with a relatively low diameter, in which it is held on catheter 22. Once in position: (Step (b)) stent 20 is expanded by a balloon 26 of catheter 22, whereby the diameter of stent 20 increases to its deployment configuration. This mechanical deformation is performed in martensite, with a deformation strain not exceeding ε2 while having high mechanical strength and being fatigue resistant. The stent 22 can then be removed (Step (c)), and the stent will thus become deployed supporting the walls of the tubular organ.
The stent of this embodiment is designed so that it can undergo an austenitic transformation with a deformation which is in a direction opposite to that of the mechanical deformation. In this case, the heating of the stent to a temperature above A,,' (Step (d)), e.g. by means of a warm saline, will cause the stent to shrink to its austenitic configuration, in which it can be removed or redeployed.
Another embodiment of this stent can be seen in Fig. 5. This embodiment, like elements to those of Fig. 4, has been given the same reference involved with a " ' " indication. Steps (a) and (b) are essentially similar to steps (a) and (b) of Fig. 4. In this case, the stent 20' has been made such that the austenitic transformation causes a change in the configuration which goes in the same direction as the mechanical deformation. Thus, by heating the temperature above A,.' (Step (c)), the stent increases in diameter and thereby exerts a stronger force on the surrounding tissue, as a result of the super elastic properties in the austenitic state.
Fig. 6 shows a stent 30, in accordance with another embodiment, which as can be seen in the cross section of the view on the left, is a composite material comprising an SMA 32, coated by another component 34, which may be a substance with plastic (low recoil ) properties, elastic (high recoil) properties, or intermediate properties between the two. By applying a mechanical force, e.g. by a balloon, as in figs. 4 or 5, the stent 30 expands from an initial configuration (a) to an operational configuration (b). This mechanical deformation is in fact, a "simulated plastic deformation" as explained above. By cooling to a temperature below TR (c), the component 34 acts to shrink the stent toward its initial state of (c). It should be noted that rather than coating a second component in the manner described above, the association of the second component to the SMA may be by a variety of other means, e.g. containing an SMA stent within a sleeve made of a plastic substance, by adding one or more restraining members, etc.
The substance from which the second component is made, may typically be a plastic polymeric material, e.g. cardiological polyurethane. However it may also be made from other substances, e.g. metal, rubber, etc.
The stent in the embodiment shown in Figs. 4-6, may have, for example, an initial diameter of 1.5-2.5 mm., and then may be expanded mechanically to a diameter of about 3.5-4.5 mm. The deformation between a diameter of 2 mm. to a diameter of 3.5 mm. induces a strain of about 2%. The deformation from 1.5 mm. to 4 mm. induces a strain of about 8%.
Fig. 7 shows a surgical staple 40, which has an initial straight shaped configuration 42 (a), and is then deformed mechanically in martensite, into a deployment configuration 44 (b). The staple, which is made of an SMA, has an austenitic configuration such that the austenitic transformation yields a deformation which goes in the direction opposite to the mechanical deformation. Thus, by heating, the staple opens to its initial configuration, and can then be removed (c). In Fig. 8, a similar surgical staple is shown, and accordingly like elements have been given like numbers with a prime indication. In this case, the austentic transformation induces a deformation which goes in the same direction to that of the mechanical deformation, and accordingly, by heating a surgical staple with a higher strain deformation 46, is obtained (c). This serves to further strengthen the tissue binding properties of the staple.
Fig. 9 shows a bone fixation device (50), which comprises two members 52 and 54, which are screw fitted with one another, with member 54 having an external screw thread at its end 56, for a tight screw engagement with the surrounding bone tissue 58. The device further comprises a tensioning cable 60, made of SMA. In order to fix a fracture 62, in the bone, a bore 64, is drilled in the bone, and the device is inserted until the end 56 is tightly screwed into the bone tissue at the end of the bore, and the head 66 of member 52, rests on the bone's exterior surface. During its screw fitting into the bone tissue, members 52 and 54 move slightly apart from one another and consequently, tensioning cable 60 becomes tensioned from its initial loose state (a) to a tensioned state (b). In one embodiment, the austenitic transformation gives rise to a deformation which is in the opposite direction to the mechanical deformation, and consequently, upon heating a temperature above A..' (c), cable 60 transforms to austenite and thus forces the two members 52 and 54 together _ o __
even further (represented by the relatively large arrow 68) thereby pressing the two fractured bone pieces tightly one towards the other.
Fig. 10 shows a bone anchoring device. The device generally designated 80, has a crown 82, and anchoring legs 84, made of an SMA. The device further has a tensioning arrangement comprising a sphere 86, which is at the end of a rod 88, which is externally screw-threaded at its end 90, and a bolt 92 screw-coupled to end 90. A mechanical tensioning force can be applied by turning bolt 92, pulling sphere 86 from its initial position (a) to a deployed position (b), with this yielding expansion of legs 84. The SMA has an austenitic configuration, such that that the deformation in the austentic transformation is in the same direction to that of the mechanical deformation; accordingly, after heating to a temperature above A., (c) legs 84, expand even further and provide, by virtue of their super- elasticity, a constant force on the surrounding bone tissue. A bone anchoring device according to another embodiment of the invention is shown in Fig. 11. Similar elements to those of Fig. 10 have been given the same reference numeral as in Fig. 10 within the prime indication. In this case, anchoring legs 94 are in an MIMS, and are maintained in that state, by the restraining force of plastic band 96. By the application of mechanical force, legs 94. epand, transforming into austenite against the mechanical force of band 96; the overall effect is that of a simulated plastic deformation, ensuring that the mechanical deformation will be a simulated plastic deformation.

Claims

CLAIMS:
1. A medical device for deployment in a body of an individual, comprising a shape memory alloy (SMA) portion having an austenitic and a martensitic state, with different memorized configurations in each of these states, and being transformable between the martensitic state to the austenitic state by an austenitic transformation occurring at an austenitic transformation temperature, and from the austenitic state to the martensitic state by a martensitic transformation occurring at a martensitic transforma- tion temperature, the SMA being initially in a martensitic state and having an initial configuration which is either a memorized martensitic configuration of the SMA or a configuration assumed by the SMA portion by a mechanical deformation; the SMA portion being mechanically deformable from the initial configuration into an operational configuration to be assumed by it when deployed within the body; the SMA portion in the operational configuration is either in a martensitic state and having a memorized austenitic configuration to which it transforms when heated to a temperature, equal or above the austenitic transformation temperature, which is above body temperature, or is in an austenitic state, to which it transformed during the mechanical deformation.
2. A medical device according to Claim 1, wherein the SMA portion has in its operational configuration, an Af', a finish temperature of the austenitic transformation in said operational configuration, which is higher than physiological body temperature, TB, and an Ms, which is a start temperature of the martensitic transformation, which is lower than TB; the SMA portion being deformable, while retaining its martensitic state into said operational configuration; upon heating of the SMA portion to a temperature above A/, it undergoes an austenitic transformation into the austenitic configuration, which is a different configuration than said operational configuration, and remains in the austenitic configuration after the temperature of the SMA returns to TB
3. A medical device according to Claim 2, wherein the austenitic configuration is such so that the transformation from the operational configuration to the austenitic configuration, when heating the device to a temperature above Af, goes in the direction opposite to that of said mechanical deformation.
4. A medical device according to Claim 2, wherein the austenitic configuration is such so that the transformation from the operational configuration to the austenitic configuration, upon heating of the device to a temperature above Af, goes in a same direction to that of said mechanical deformation.
5. A medical device according to Claim 2, having a martensitic configuration assumed by it after a temperature-induced martensitic transformation, which is about the same as the deployment configuration.
6. A device according to Claim 2, having an intermediate state R, between the martensitic and the austenitic states, and having a transformation temperature from the austenitic state to the R state TR, which is higher than Ms and being close to TB, such that at body temperature, the SMA portion is entirely or partially in the R state.
7. A medical device according to Claim 2, wherein the deformation of the SMA from the initial shape to the deployment shape is with a strain within a range of ╬╡ ,-╬╡2, with ╬╡ , being a strain level at an end of a horizontal plateau of a stress-strain curve of the SMA, and ╬╡2 is an upper limit of deformation recoverable by a shape memory effect.
8. A medical device according to Claim 2, wherein the forced deformation of the SMA portion causes an increase in the austenitic transformation temperature from initial start and finish transformation temperatures of the austenitic transformations, A,' and Af', respectively, which are below TB, to austenitic start and finish transformations in the operational configuration, A and Af', respectively, higher than TB.
9. A device according to Claim 8, having an R phase with a TR close to TB and is mechanically deformable such that at least one segment of the SMA portion remains in the R phase and at least one other segment is deformed with a strain at a range of εχ-ε2.
10. a device according to Claim 1, comprising:
A first component and a second component associated with one another, such that a deforming mechanical force cause both to deform together; the first component comprising an SMA having an initial configuration in which the SMA is in a mechanically induced martensitic state (MIMS) resulting from a strain-induced or stress-induced martensitic transformation; the second component having mechanical properties such that it resists deformation at a stress, σ2, which is larger than stress generated by the SMA when released from said MIMS to the austenitic stress, όi, thereby restraining said SMA in said initial state; the SMA together with the plastic element are mechanically deformable from said initial configuration to an operational configuration, this deformation causing the SMA to transform from said MIMS to the austenitic state; the plastic element yielding a reactive stress, σ2, which is less than the resistive stress, σ3 of the deformation of the SMA from the operational configuration to said initial configuration, whereby the device is retained in said operational configuration.
11. A device according to Claim 10, wherein said second component has a low recoil.
12. A device according to Claim 10, wherein the second component has a high recoil, and the SMA has an R phase with a TR transformation temperature below TB, whereby upon cooling of the SMA to TR or below, there is a sharp drop of the SMA's elastic modulus giving rise to a decrease in stiffness of the SMA such that said second component can then deform the SMA portion up to at least said initial configuration.
13. A device according to Claim 1 being a member of the group consisting of a stent, surgical staple, bone anchor device and bone fraction fixation device.
PCT/IL1998/000467 1997-09-30 1998-09-27 Medical devices of shape memory alloys WO1999016385A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU93650/98A AU9365098A (en) 1997-09-30 1998-09-27 Medical devices of shape memory alloys

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/940,525 US5964770A (en) 1997-09-30 1997-09-30 High strength medical devices of shape memory alloy
US08/940,525 1997-09-30

Publications (1)

Publication Number Publication Date
WO1999016385A1 true WO1999016385A1 (en) 1999-04-08

Family

ID=25474974

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL1998/000467 WO1999016385A1 (en) 1997-09-30 1998-09-27 Medical devices of shape memory alloys

Country Status (3)

Country Link
US (1) US5964770A (en)
AU (1) AU9365098A (en)
WO (1) WO1999016385A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106642A (en) * 1998-02-19 2000-08-22 Boston Scientific Limited Process for the improved ductility of nitinol
US6656178B1 (en) 1999-07-28 2003-12-02 Baat B.V. Engineering Vertebral-column fusion devices and surgical methods
US6685708B2 (en) * 2000-09-07 2004-02-03 Niti Alloys Technologies Ltd. Staples for bone fixation
ES2253061A1 (en) * 2004-03-09 2006-05-16 Neos Surgery, S.L. Closing device for trepanation orifices and craniectomia orifices includes deformable media comprised of elastic material constituted of metallic element or metallic alloy
ES2253083A1 (en) * 2004-07-05 2006-05-16 Neos Surgery, S.L. Device for fastening post-craniotomy bone flaps
US7335426B2 (en) 1999-11-19 2008-02-26 Advanced Bio Prosthetic Surfaces, Ltd. High strength vacuum deposited nitinol alloy films and method of making same
DE102007050666A1 (en) * 2007-10-24 2009-04-30 Biotronik Vi Patent Ag Nitinol stent with improved axial flexural rigidity and associated manufacturing process
US8910363B2 (en) 1999-11-19 2014-12-16 Advanced Bio Prosthetic Surfaces, Ltd. Compliant implantable medical devices and methods of making same
US9284637B2 (en) 1999-11-19 2016-03-15 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Implantable graft and methods of making same
CN105658183A (en) * 2013-05-23 2016-06-08 Sts医疗有限公司 Shape change structure
US9463305B2 (en) 1999-11-19 2016-10-11 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Balloon catheter having metal balloon and method of making same
WO2018201111A3 (en) * 2017-04-28 2018-12-13 Medtronic Inc. Shape memory articles and methods for controlling properties
US10912663B2 (en) 2014-11-26 2021-02-09 S.T.S. Medical Ltd. Shape change structure for treatment of nasal conditions including sinusitis

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2192520A1 (en) 1996-03-05 1997-09-05 Ian M. Penn Expandable stent and method for delivery of same
CA2248718A1 (en) 1996-03-05 1997-09-12 Divysio Solutions Ulc. Expandable stent and method for delivery of same
US6796997B1 (en) 1996-03-05 2004-09-28 Evysio Medical Devices Ulc Expandable stent
US6068623A (en) * 1997-03-06 2000-05-30 Percusurge, Inc. Hollow medical wires and methods of constructing same
US20020055717A1 (en) * 1997-10-20 2002-05-09 Philippe Poncet Fluid-based agent delivery device with self-expanding delivery element
US6325820B1 (en) 1998-11-16 2001-12-04 Endotex Interventional Systems, Inc. Coiled-sheet stent-graft with exo-skeleton
US8092514B1 (en) 1998-11-16 2012-01-10 Boston Scientific Scimed, Inc. Stretchable anti-buckling coiled-sheet stent
US8382821B2 (en) 1998-12-03 2013-02-26 Medinol Ltd. Helical hybrid stent
US20040267349A1 (en) * 2003-06-27 2004-12-30 Kobi Richter Amorphous metal alloy medical devices
ATE379998T1 (en) * 1999-01-26 2007-12-15 Edwards Lifesciences Corp FLEXIBLE HEART VALVE
US6736845B2 (en) 1999-01-26 2004-05-18 Edwards Lifesciences Corporation Holder for flexible heart valve
US20010042501A1 (en) * 2000-05-17 2001-11-22 Park Ji-Hoon Temperature sensor using shape memory alloy and manufacturing method thereof
US20050043757A1 (en) * 2000-06-12 2005-02-24 Michael Arad Medical devices formed from shape memory alloys displaying a stress-retained martensitic state and method for use thereof
US6679886B2 (en) 2000-09-01 2004-01-20 Synthes (Usa) Tools and methods for creating cavities in bone
US7976648B1 (en) 2000-11-02 2011-07-12 Abbott Cardiovascular Systems Inc. Heat treatment for cold worked nitinol to impart a shape setting capability without eventually developing stress-induced martensite
US6602272B2 (en) * 2000-11-02 2003-08-05 Advanced Cardiovascular Systems, Inc. Devices configured from heat shaped, strain hardened nickel-titanium
US6855161B2 (en) 2000-12-27 2005-02-15 Advanced Cardiovascular Systems, Inc. Radiopaque nitinol alloys for medical devices
US7082868B2 (en) 2001-03-15 2006-08-01 Ati Properties, Inc. Lightweight armor with repeat hit and high energy absorption capabilities
WO2002087473A1 (en) * 2001-04-26 2002-11-07 Vascular Innovation, Inc. Endoluminal device and method for fabricating same
US6551341B2 (en) * 2001-06-14 2003-04-22 Advanced Cardiovascular Systems, Inc. Devices configured from strain hardened Ni Ti tubing
WO2003018853A2 (en) * 2001-08-24 2003-03-06 University Of Virginia Patent Foundation Reversible shape memory multifunctional structural designs and method of using and making the same
AU2002323457A1 (en) * 2001-08-27 2003-05-19 James C. Thomas Jr. Implant for partial disc and cancellous bone replacement
SG108867A1 (en) 2001-09-06 2005-02-28 Medinol Ltd Self articulating stent
US7189258B2 (en) * 2002-01-02 2007-03-13 Medtronic, Inc. Heart valve system
US7033390B2 (en) * 2002-01-02 2006-04-25 Medtronic, Inc. Prosthetic heart valve system
US6783438B2 (en) * 2002-04-18 2004-08-31 Ormco Corporation Method of manufacturing an endodontic instrument
US7779542B2 (en) * 2002-04-18 2010-08-24 Ormco Corporation Method of manufacturing a dental instrument
US7240677B2 (en) * 2003-02-03 2007-07-10 Biomedical Enterprises, Inc. System and method for force, displacement, and rate control of shaped memory material implants
JP2006523770A (en) * 2003-04-18 2006-10-19 ザ ユニバーシティ オブ ホンコン Shape memory material and method of manufacturing the same
US7942892B2 (en) 2003-05-01 2011-05-17 Abbott Cardiovascular Systems Inc. Radiopaque nitinol embolic protection frame
US7491227B2 (en) * 2003-06-16 2009-02-17 Boston Scientific Scimed, Inc. Coiled-sheet stent with flexible mesh design
US9039755B2 (en) 2003-06-27 2015-05-26 Medinol Ltd. Helical hybrid stent
US9155639B2 (en) 2009-04-22 2015-10-13 Medinol Ltd. Helical hybrid stent
US20050059994A1 (en) * 2003-09-17 2005-03-17 Steven Walak Fatigue resistant medical devices
DE10355815B4 (en) * 2003-11-28 2006-06-29 Universität Zu Lübeck Electrode for nerve tissue
JP2005160648A (en) * 2003-12-01 2005-06-23 Terumo Corp Wire and medical instrument for removing foreign body in blood vessel
NL1025830C2 (en) * 2004-03-26 2005-02-22 Eric Berreklouw Prosthesis e.g. heart valve secured in place by ring with shape memory material anchor, includes anchor temperature control system
US20050245932A1 (en) * 2004-04-16 2005-11-03 Fanton Gary S Apparatus and methods for securing tissue to bone
US20060282081A1 (en) * 2004-04-16 2006-12-14 Fanton Gary S Apparatus and method for securing tissue to bone with a suture
US7985222B2 (en) * 2004-04-21 2011-07-26 Medshape Solutions, Inc. Osteosynthetic implants and methods of use and manufacture
US7775968B2 (en) 2004-06-14 2010-08-17 Pneumrx, Inc. Guided access to lung tissues
JP2008503254A (en) * 2004-06-16 2008-02-07 ヌームアールエックス・インコーポレーテッド Intrabronchial lung volume reduction system
EP1781182B1 (en) 2004-07-08 2019-11-13 PneumRx, Inc. Pleural effusion treatment device
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
US7799078B2 (en) * 2004-11-12 2010-09-21 Warsaw Orthopedic, Inc. Implantable vertebral lift
JP4874259B2 (en) 2004-11-23 2012-02-15 ヌームアールエックス・インコーポレーテッド Steerable device for accessing the target site
FR2881946B1 (en) * 2005-02-17 2008-01-04 Jacques Seguin DEVICE FOR THE TREATMENT OF BODILY CONDUIT AT BIFURCATION LEVEL
US20060206199A1 (en) * 2005-03-12 2006-09-14 Churchwell Stacey D Aneurysm treatment devices
US20060206198A1 (en) * 2005-03-12 2006-09-14 Churchwell Stacey D Aneurysm treatment devices and methods
US8062359B2 (en) * 2005-04-06 2011-11-22 Edwards Lifesciences Corporation Highly flexible heart valve connecting band
US20060247679A1 (en) * 2005-04-29 2006-11-02 Sdgi Holdings, Inc. Compression device and method for shape memory alloy implants
US20060247753A1 (en) * 2005-04-29 2006-11-02 Wenger William K Subcutaneous lead fixation mechanisms
CA2608693A1 (en) 2005-05-18 2006-11-23 Sonoma Orthopedic Products, Inc. Minimally invasive actuable bone fixation devices, systems and methods of use
US8287541B2 (en) 2005-05-18 2012-10-16 Sonoma Orthopedic Products, Inc. Fracture fixation device, tools and methods
US9060820B2 (en) 2005-05-18 2015-06-23 Sonoma Orthopedic Products, Inc. Segmented intramedullary fracture fixation devices and methods
US8961516B2 (en) 2005-05-18 2015-02-24 Sonoma Orthopedic Products, Inc. Straight intramedullary fracture fixation devices and methods
GB0521582D0 (en) 2005-10-22 2005-11-30 Depuy Int Ltd An implant for supporting a spinal column
GB0600662D0 (en) 2006-01-13 2006-02-22 Depuy Int Ltd Spinal support rod kit
US8348952B2 (en) 2006-01-26 2013-01-08 Depuy International Ltd. System and method for cooling a spinal correction device comprising a shape memory material for corrective spinal surgery
US20070173800A1 (en) * 2006-01-26 2007-07-26 Depuy Spine, Inc. System and method for heating a shape memory material spinal correction element for corrective spinal surgery
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US9801637B2 (en) 2006-03-13 2017-10-31 Pneumrx, Inc. Genetically-associated chronic obstructive pulmonary disease treatment
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
EP1996084A1 (en) * 2006-03-22 2008-12-03 Sapphire Medical, Inc. Suture passer devices and uses thereof
US8360361B2 (en) 2006-05-23 2013-01-29 University Of Virginia Patent Foundation Method and apparatus for jet blast deflection
US20080065153A1 (en) * 2006-09-08 2008-03-13 Warsaw Orthopedic, Inc. Surgical staple
US20080065154A1 (en) * 2006-09-08 2008-03-13 Warsaw Orthopedic, Inc Surgical staple
AU2007323566A1 (en) 2006-11-22 2008-05-29 Sonoma Orthopedic Products, Inc. Fracture fixation device, tools and methods
ATE499912T1 (en) * 2006-12-04 2011-03-15 Cook Inc METHOD FOR INSERTING A MEDICAL DEVICE INTO A RELEASE SYSTEM
EP2120753B1 (en) * 2007-03-05 2022-09-28 Tornier, Inc. Tack anchor systems
WO2008112894A1 (en) * 2007-03-15 2008-09-18 Jiayi Li Devices, systems, kits and methods for treatment of obesity
US8273118B2 (en) * 2007-09-17 2012-09-25 Medtronic, Inc. Heart valve holder assembly for use in valve implantation procedures
AU2008304187B2 (en) 2007-09-26 2013-09-12 Ultradent Products, Inc. Methods, devices, systems, assemblies, and kits for tissue retraction in an oral cavity
GB0720762D0 (en) 2007-10-24 2007-12-05 Depuy Spine Sorl Assembly for orthopaedic surgery
WO2009085829A2 (en) * 2007-12-19 2009-07-09 Sevrain Lionel C Spring-assisted cranial clamp
CN102056575B (en) * 2008-04-23 2015-04-01 库克医药技术有限责任公司 Method of loading a medical device into a delivery system
US20100063548A1 (en) * 2008-07-07 2010-03-11 Depuy International Ltd Spinal Correction Method Using Shape Memory Spinal Rod
US9005274B2 (en) 2008-08-04 2015-04-14 Stentys Sas Method for treating a body lumen
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
EP2341857A2 (en) 2008-09-26 2011-07-13 Sonoma Orthopedic Products, Inc. Bone fixation device, tools and methods
EP2432422A4 (en) 2009-05-18 2018-01-17 PneumRx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
EP2501299B1 (en) 2009-11-16 2016-03-23 Tornier, Inc. Bone implant with convertible suture attachment
JP6295318B2 (en) 2013-03-15 2018-03-14 ニュームアールエックス・インコーポレイテッドPneumrx, Inc. Torque-releasing airway lung volume reduced compression implant structure
CN105142495B (en) 2013-03-15 2018-07-17 厄耳他拉登脱产品股份有限公司 Cheek pull device and method
US10016192B2 (en) 2013-06-14 2018-07-10 Tornier, Inc. Suture for connecting a human or animal tissue, soft anchor and method for attaching a tissue to a bone
WO2015061790A2 (en) 2013-10-25 2015-04-30 Pneumrx, Inc. Genetically-associated chronic obstructive pulmonary disease treatment
US9770278B2 (en) 2014-01-17 2017-09-26 Arthrex, Inc. Dual tip guide wire
US9498266B2 (en) * 2014-02-12 2016-11-22 Wright Medical Technology, Inc. Intramedullary implant, system, and method for inserting an implant into a bone
USD763444S1 (en) 2014-03-14 2016-08-09 Ultradent Products, Inc. Cheek retractor device
USD737964S1 (en) 2014-03-14 2015-09-01 Ultradent Products, Inc. Cheek retractor device
US10588642B2 (en) * 2014-05-15 2020-03-17 Gauthier Biomedical, Inc. Molding process and products formed thereby
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
US9814499B2 (en) 2014-09-30 2017-11-14 Arthrex, Inc. Intramedullary fracture fixation devices and methods
USD792590S1 (en) 2015-07-21 2017-07-18 Ultradent Products, Inc. Cheek retractor device
US20170082499A1 (en) * 2015-09-22 2017-03-23 Empire Technology Development Llc Temperature tags and methods for their preparation and use
USD914214S1 (en) 2019-06-03 2021-03-23 Ultradent Products, Inc. Dental retraction device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0395098A1 (en) * 1989-04-28 1990-10-31 Tokin Corporation Readily operable catheter guide wire using shape memory alloy with pseudo elasticity
US5545210A (en) * 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5624508A (en) * 1995-05-02 1997-04-29 Flomenblit; Josef Manufacture of a two-way shape memory alloy and device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485816A (en) * 1981-06-25 1984-12-04 Alchemia Shape-memory surgical staple apparatus and method for use in surgical suturing
US4665906A (en) * 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
WO1989003197A1 (en) * 1987-10-08 1989-04-20 Terumo Kabushiki Kaisha Instrument and apparatus for securing inner diameter of lumen of tubular organ
IL105828A (en) * 1993-05-28 1999-06-20 Medinol Ltd Medical stent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0395098A1 (en) * 1989-04-28 1990-10-31 Tokin Corporation Readily operable catheter guide wire using shape memory alloy with pseudo elasticity
US5545210A (en) * 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5624508A (en) * 1995-05-02 1997-04-29 Flomenblit; Josef Manufacture of a two-way shape memory alloy and device

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106642A (en) * 1998-02-19 2000-08-22 Boston Scientific Limited Process for the improved ductility of nitinol
US6540849B2 (en) 1998-02-19 2003-04-01 Scimed Life Systems, Inc. Process for the improved ductility of nitinol
US6656178B1 (en) 1999-07-28 2003-12-02 Baat B.V. Engineering Vertebral-column fusion devices and surgical methods
US9284637B2 (en) 1999-11-19 2016-03-15 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Implantable graft and methods of making same
US9463305B2 (en) 1999-11-19 2016-10-11 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Balloon catheter having metal balloon and method of making same
US10745799B2 (en) 1999-11-19 2020-08-18 Vactronix Scientific, Llc Compliant implantable medical devices and methods of making same
US7335426B2 (en) 1999-11-19 2008-02-26 Advanced Bio Prosthetic Surfaces, Ltd. High strength vacuum deposited nitinol alloy films and method of making same
US10292849B2 (en) 1999-11-19 2019-05-21 Vactronix Scientific, Llc Balloon catheter having metal balloon and method of making same
US7670690B2 (en) 1999-11-19 2010-03-02 Advanced Bio Prosthetic Surfaces, Ltd. High strength vacuum deposited nitinol alloy films and method of making same
US8083908B2 (en) 1999-11-19 2011-12-27 Advanced Bio Prosthetic Surfaces, Ltd. High strength vacuum deposited nitinol alloy films and method of making same
US10106884B2 (en) 1999-11-19 2018-10-23 Vactronix Scientific, Llc Compliant implantable medical devices and methods of making same
US8910363B2 (en) 1999-11-19 2014-12-16 Advanced Bio Prosthetic Surfaces, Ltd. Compliant implantable medical devices and methods of making same
US6685708B2 (en) * 2000-09-07 2004-02-03 Niti Alloys Technologies Ltd. Staples for bone fixation
US10465274B2 (en) 2002-09-26 2019-11-05 Vactronix Scientific, Llc Implantable graft and methods of making same
ES2253061A1 (en) * 2004-03-09 2006-05-16 Neos Surgery, S.L. Closing device for trepanation orifices and craniectomia orifices includes deformable media comprised of elastic material constituted of metallic element or metallic alloy
ES2253083A1 (en) * 2004-07-05 2006-05-16 Neos Surgery, S.L. Device for fastening post-craniotomy bone flaps
US8157859B2 (en) 2007-10-24 2012-04-17 Biotronik Vi Patent Ag Stent made of nitinol having improved axial bending stiffness and associated production method
DE102007050666A1 (en) * 2007-10-24 2009-04-30 Biotronik Vi Patent Ag Nitinol stent with improved axial flexural rigidity and associated manufacturing process
CN105658183B (en) * 2013-05-23 2018-11-27 Sts医疗有限公司 Shape changes structure
CN105658183A (en) * 2013-05-23 2016-06-08 Sts医疗有限公司 Shape change structure
US10953141B2 (en) 2013-05-23 2021-03-23 S.T.S. Medical Ltd. Shape change structure
US10912663B2 (en) 2014-11-26 2021-02-09 S.T.S. Medical Ltd. Shape change structure for treatment of nasal conditions including sinusitis
WO2018201111A3 (en) * 2017-04-28 2018-12-13 Medtronic Inc. Shape memory articles and methods for controlling properties
CN110582587A (en) * 2017-04-28 2019-12-17 美敦力公司 shape memory article and method of performance control
US11672883B2 (en) 2017-04-28 2023-06-13 Medtronic, Inc. Shape memory articles and methods for controlling properties

Also Published As

Publication number Publication date
US5964770A (en) 1999-10-12
AU9365098A (en) 1999-04-23

Similar Documents

Publication Publication Date Title
US5964770A (en) High strength medical devices of shape memory alloy
Duerig et al. The utility of superelasticity in medicine
US5876434A (en) Implantable medical devices of shape memory alloy
US6306141B1 (en) Medical devices incorporating SIM alloy elements
Duerig et al. An overview of nitinol medical applications
CA1246956A (en) Shape memory alloys
US4665906A (en) Medical devices incorporating sim alloy elements
Petrini et al. Biomedical applications of shape memory alloys
US4170990A (en) Method for implanting and subsequently removing mechanical connecting elements from living tissue
KR100656725B1 (en) Self-expanding endoprosthesis
Duerig et al. The use of superelasticity in medicine
AU774230B2 (en) Medical instruments and devices and parts thereof using shape memory alloys
JP4623792B2 (en) Intravascular stent with tapered struts
US20050043757A1 (en) Medical devices formed from shape memory alloys displaying a stress-retained martensitic state and method for use thereof
US20080274011A1 (en) Shape memory alloy endoprosthesis delivery system
WO2006104823A3 (en) Method for producing strain induced austenite
Van Humbeeck et al. Shape memory alloys
US20040087997A1 (en) Medical devices incorporating elastically deformable SIM elements
Schmerling et al. A proposed medical application of the shape memory effect: a NiTi Harrington rod for the treatment of scoliosis
Sachdeva et al. Nitinol as a biomedical material
EP0828860A1 (en) MEDICAL, DENTAL AND ORTHODONTIC ARTICLES OF Ni-Ti-Nb ALLOYS
AU4888400A (en) Self-deformable connecting device for use in the creation of a vascular bypass

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase